Novartis (NVS)
(Delayed Data from NYSE)
$97.44 USD
-1.62 (-1.64%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $97.41 -0.03 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth A Momentum C VGM
Brokerage Reports
0 items in cart
Novartis AG [NVS]
Reports for Purchase
Showing records 461 - 473 ( 473 total )
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
New and Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
New Drug Launch Weekly Retail Sales Tracker - Week Ended June 21
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Biotechnology/Biopharmaceuticals/BioDefense-New Drug Launch Weekly Retail Sales Tracker - Week Ending May 10
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Biotechnology/Biopharmaceuticals/BioDefense-New Drug Launch Weekly Retail Sales Tracker - Week ending February 22, 2013
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Griffin Securities Updates Coverage on Ligand Pharma. (LGND)
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Biotechnology / Biopharmaceuticals -Preview of Gout Abstracts at the Upcoming ACR
Provider: WEDBUSH SECURITIES INC.
Analyst: XU Y
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Calendar of Events
Provider: WALL STREET ACCESS CORP.
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
RISK ARB TRADING UPDATE.
Provider: WALL STREET ACCESS CORP.
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
MERGERS & ACQUISITIONS
Provider: WALL STREET ACCESS CORP.
Company: Novartis AG
Industry: Medical - Drugs
Company: Novartis AG
Industry: Medical - Drugs
Novartis agrees to exercise its call option to buy remainder of Alcon''s shares
Provider: IIR GROUP
Analyst: KHAN F